Literature DB >> 1902147

IFN-gamma enhances secretion of IgG2a from IgG2a-committed LPS-stimulated murine B cells: implications for the role of IFN-gamma in class switching.

A Bossie1, E S Vitetta.   

Abstract

IFN-gamma is a pleiotropic lymphokine that influences the isotypes of immunoglobulin secreted by B cells. IFN-gamma inhibits the secretion of IgG3, IgG2b, IgG1, and IgE, and enhances the secretion of IgG2a. We have examined the mechanism of IFN-gamma-mediated enhancement of IgG2a secretion in sorted populations of B cells and find that IFN-gamma reproducibly stimulates a twofold increase in the precursor frequency of IgG2a-secreting cells in the sIgG2a+ population. Additionally, we find that IFN-gamma does not induce an increase in the clone size of IgG2a-secreting cells. IFN-gamma stimulates a twofold increase in the precursor frequency of IgG2a-secreting cells from sIgG- and unsorted B cells which can be attributed to an increase in IgG2a secretion from IgG2a-committed cells in these populations. Hence, under the culture conditions utilized in these studies. IFN-gamma enhances IgG2a secretion from IgG2a-committed cells and does not induce a class switch.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902147     DOI: 10.1016/0008-8749(91)90257-c

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  31 in total

1.  Spontaneous autoimmunity in the absence of IL-2 is driven by uncontrolled dendritic cells.

Authors:  Sara H Isakson; Shoshana D Katzman; Katrina K Hoyer
Journal:  J Immunol       Date:  2012-07-09       Impact factor: 5.422

2.  Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis.

Authors:  J M Spergel; E Mizoguchi; H Oettgen; A K Bhan; R S Geha
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 3.  Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses.

Authors:  C E Taylor
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

4.  Class switch recombination in selective IgA-deficient subjects.

Authors:  L Hummelshoj; L P Ryder; L K Nielsen; C H Nielsen; L K Poulsen
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

5.  Stat1 Regulates Lupus-like Chronic Graft-versus-Host Disease Severity via Interactions with Stat3.

Authors:  Wen-Hai Shao; Ana M Gamero; Yuxuan Zhen; Monica J Lobue; Stephen O Priest; Hazem J Albandar; Philip L Cohen
Journal:  J Immunol       Date:  2015-09-21       Impact factor: 5.422

6.  Collagen-induced arthritis: severity and immune response attenuation using multivalent N-acetyl glucosamine.

Authors:  J Richter; K Capková; V Hříbalová; L Vannucci; I Danyi; M Malý; A Fišerová
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

7.  IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice.

Authors:  Deborah L Hodge; Cyril Berthet; Vincenzo Coppola; Wolfgang Kastenmüller; Matthew D Buschman; Paul M Schaughency; Hidekazu Shirota; Anthony J Scarzello; Jeff J Subleski; Miriam R Anver; John R Ortaldo; Fanching Lin; Della A Reynolds; Michael E Sanford; Philipp Kaldis; Lino Tessarollo; Dennis M Klinman; Howard A Young
Journal:  J Autoimmun       Date:  2014-02-28       Impact factor: 7.094

8.  Anti-allergic effects of So-Cheong-Ryong-Tang, a traditional Korean herbal medicine, in an allergic rhinitis mouse model.

Authors:  Ji-Hun Mo; Seung-Eun Lee; Jee Hye Wee; Ji-Eun Lee; Chae-Seo Rhee; Chul Hee Lee; Dong-Young Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-19       Impact factor: 2.503

9.  Delineation of the role of platelet-activating factor in the immunoglobulin G2 antibody response.

Authors:  Salma Al-Darmaki; Kandi Knightshead; Yuichi Ishihara; Al Best; Harvey A Schenkein; John G Tew; Suzanne E Barbour
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

10.  Chronic inhibition of cyclooxygenase-2 attenuates antibody responses against vaccinia infection.

Authors:  Matthew P Bernard; Simona Bancos; Timothy J Chapman; Elizabeth P Ryan; John J Treanor; Robert C Rose; David J Topham; Richard P Phipps
Journal:  Vaccine       Date:  2009-11-24       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.